GSE Group:企業の戦略・SWOT・財務情報

◆英語タイトル:GSE Group - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6050
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GSE Group – Strategy, SWOT and Corporate Finance Report
Summary

GSE Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GSE Group (GSE) is a construction contractor. The company provides a wide range of services across all stages of the project such as design and build, engineering, technical and architectural design, operation and maintenance, construction, land search, quality and safety initiatives, project management, and financial and legal arrangements. The company also focuses on eco-construction and sustainable building projects. It offers services for various construction projects such as production and research units, logistics facilities, service and leisure facilities, warehouses, offices and headquarters, and healthcare center industries. The company owns regional branches in France, Germany, Hungary, Italy, Poland, the UK, Spain and China. GSE is headquartered in Avignon, France.

Scope

- Detailed information on GSE Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GSE Group in the form of a SWOT analysis
- An in-depth view of the business model of GSE Group including a breakdown and examination of key business segments
- Intelligence on GSE Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GSE Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GSE Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GSE Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GSE Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
GSE Group: Company Overview 6
GSE Group: Overview and Key Facts 6
GSE Group: Overview 6
GSE Group: Key Facts 6
GSE Group: Key Employees 7
GSE Group: Major Products and Services 8
GSE Group: Company History 9
GSE Group: Management Statement 12
GSE Group: Locations and Subsidiaries 13
GSE Group: Key Competitors 16
GSE Group: Company Analysis 17
GSE Group: Business Description 17
GSE Group: SWOT Analysis 18
GSE Group: SWOT Overview 18
GSE Group: Strengths 18
GSE Group: Weaknesses 19
GSE Group: Opportunities 19
GSE Group: Threats 20
GSE Group: Recent Developments 21
GSE Group: News and Events Summary 21
GSE Group: Contracts 22
GSE Group: Corporate Governance 25
GSE Group: Strategy and Operations 25
Appendix 27
Contact Us 27
Methodology 27
About MarketLine 28

List of Tables
Table 1: GSE Group: Key Facts
Table 2: GSE Group: Key Employees
Table 3: GSE Group: Company History
Table 4: GSE Group: Locations and Subsidiaries
Table 5: GSE Group: Key Competitors
Table 6: GSE Group: News and Events Summary
Table 7: GSE Group: Contracts
Table 8: GSE Group: Corporate Governance
Table 9: GSE Group: Strategy and Operations



★海外企業調査レポート[GSE Group:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Factor Therapeutics Ltd (FTT)-製薬・医療分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …
  • Adani Enterprises Ltd (ADANIENT):企業の財務・戦略的SWOT分析
    Adani Enterprises Ltd (ADANIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Quest Diagnostics Inc (DGX):企業の財務・戦略的SWOT分析
    Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Petronas Dagangan Berhad (PETDAG):企業の財務・戦略的SWOT分析
    Petronas Dagangan Berhad (PETDAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Medikit Co Ltd (7749):企業の製品パイプライン分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • NCS Pte. Ltd.:企業の戦略・SWOT・財務情報
    NCS Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary NCS Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • UnitedHealth Group Inc (UNH):製薬・医療:M&Aディール及び事業提携情報
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • PulteGroup Inc (PHM):企業の財務・戦略的SWOT分析
    PulteGroup Inc (PHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Asiatravel.com Holdings Ltd:戦略・SWOT・企業財務分析
    Asiatravel.com Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Asiatravel.com Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MEC Holding GmbH:企業の戦略的SWOT分析
    MEC Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Saracen Mineral Holdings Ltd:企業の戦略・SWOT・財務分析
    Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vaxart Inc (AVIR):企業の財務・戦略的SWOT分析
    Vaxart Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vidrala S.A.:企業の戦略・SWOT・財務情報
    Vidrala S.A. - Strategy, SWOT and Corporate Finance Report Summary Vidrala S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Karo Pharma AB (KARO):製薬・医療:M&Aディール及び事業提携情報
    Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new phar …
  • T2 Biosystems Inc (TTOO):製薬・医療:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Uptake Medical Corp-製薬・医療分野:企業M&A・提携分析
    Summary Uptake Medical Corp (Uptake Med) is a healthcare technology company that develops medical technologies for the treatment of emphysema and lung cancer. The company develops intervapor therapy system, a bronchoscopic procedure in which heated water vapor is delivered to emphysematous lung tiss …
  • Histogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆